Melanoma – New options, new hope | Overview 0/1
The treatment landscape in advanced melanoma has been transformed in recent years with the development of novel pharmacological agents, with a shift towards higher response rates, prolonged disease control and the possibility of cure for some patients.
This comprehensive interactive module will give you an overview of the available treatments for patients with Stage III and IV melanoma, including the common adverse effects that GPs need to be aware of. It also covers the role of the GP in referring to a melanoma specialist and providing supportive care.
A/Prof Matteo Carlino
Medical Oncologist, Melanoma Institute Australia, Westmead and Blacktown Hospitals
Clinical Associate Professor, The University of Sydney
Declaration of Interest
Dr Linda Taoube
Lecturer, The University of Sydney
General Practitioner, Your Doctors
This education is a CPD Activity under the RACGP CPD Program.
- Recall current guidelines regarding the medical management of people with Stage III and IV melanoma.
- Identify and address common adverse effects associated with immunotherapy and targeted therapies used in the treatment of melanoma.
- Review and address the diverse emotional, psychological and social aspects associated with diagnosis, treatment and ongoing management of people with advanced melanoma, including referral pathways for psychological assessment and care.
This learning module was proudly supported through unrestricted educational grants from: